Biomarker discovery

  • Biomarker for aggressive small clear cell renal cell carcinoma

  • Therapeutic biomarker for aggressive Xp11.2 translocation renal cell carcinoma

  • Liquid biopsy - ctDNA, cfDNA, ... etc.

  • DDX11, ALK, ... etc.

Development of New treatment modality

  • Oncolytic virus (pexa-vec, JX-594) study

  • Therapeutic strategy development (combinatorial or sequential)

Microbiome

  • BPH, prostate cancer,....

  • Postoperative-ileus

Proteogenomics

  • Development of therapeutic response prediction model in metastatic clear cell renal cell carcinoma patients using serum multi-omics approach

Single-cell analysis

  • Bladder cancer: BCG response